Trouver une ressource

PQWCHC SOS Evaluation Report Summary

Fiche d’information/infographie

This infographic summarizes key findings, client-identified needs, and recommendations from the Parkdale Queen West Community Health Centre SOS: 2023…

Source: Parkdale Queen West Community Health Centre
Format: Lien
Publié : 2023
Sujets : Approvisionnement sûr

Out of Sight, Out of Mind: Addressing the Invisible and Older Faces of Canada’s Opioid Crisis

Rapport

As more attention is being paid to the opioid crisis in Canada, various responses have been launched in an attempt to curb some of these alarming tre…

Source: National Institute on Ageing
Format: PDF
Publié : 2023
Sujets : Raisons incitant les personnes à consommer des substances, Populations spécifiques

Harm Reduction and Treatment Models for Women and Gender-Diverse Persons who Use Opioids

Rapport

This review is a rapid synthesis focussed on the range of harm reduction and treatment models intended to meet the unique needs of women and gender-d…

Source: Public Health Ontario (PHO)
Format: PDF
Publié : 2022
Sujets : Populations spécifiques, Traitement et réduction des méfaits

Opioid Toxicity and Access to Treatment among Adolescents and Young Adults in Ontario

Rapport

The drug toxicity crisis is a growing public health issue among adolescents and young adults. Opioid-related emergency department (ED) visits and dea…

Source: Ontario Drug Policy Research Network (ODPRN), Public Health Ontario (PHO)
Format: PDF
Publié : 2023
Sujets : Traitement et réduction des méfaits, Populations spécifiques

Ontario Opioid Indicator Tool

Tool

The Ontario Opioid Indicator Tool provides public access to indicators of opioid use, opioid-related harms, and access to treatment and harm reductio…

Source: Ontario Drug Policy Research Network (ODPRN)
Format: Lien
Publié : 2023
Sujets : Outils de surveillance, Surveillance provinciale/territoriale et locale

Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery

Article universitaire

The COVID-19 pandemic triggered unprecedented expansion of telemedicine, including in the delivery of opioid agonist treatment (OAT) for people with …

Source: JMIR Public Health and Surveillance
Format: Lien
Publié : 2023
Sujets : Réduction des méfaits, Autres approches, Substances spécifiques

Québec Guide to Improving Practices in the Management of Opioid Use Disorder (OUD)

Guide

The Québec Guide to Improving Practices in the Management of Opioid Use Disorder (OUD) is a publication of the Institut universitaire sur les dépenda…

Source: Équipe de soutien clinique et organisationnel en dépendance et itinérance (ESCODI), Institut universitaire sur les dépendances (IUD)
Format: Lien
Publié : 2020
Sujets : Pratiques exemplaires et lignes directrices, Pratiques exemplaires et mise en œuvre, Traitement et réduction des méfaits

Audio series on opioids: In Plain Sight

Balado

We are facing a national opioid crisis. It’s affecting our friends, family and community members. While there are thousands of stories to be told, th…

Source: Health Canada
Format: Lien
Publié : 2021
Sujets : Témoignages et perspectives

Canadian Guidelines on Opioid Use Disorder Among Older Adults

Guide

This guideline on opioid use disorder (OUD) in older adults (age ≥ 65) is one in a series of four that also includes alcohol, cannabis, and benzodiaz…

Source: Canadian Coalition for Seniors Mental Health (CCSMH)
Format: PDF
Publié : 2019
Sujets : Approches axées sur l’équité, Pratiques exemplaires et lignes directrices, Substances spécifiques, Populations spécifiques

Environmental Scan: Naloxone Access and Distribution in Canada

Rapport

This document was produced in order to consolidate information on current practices in naloxone distribution and to provide a preliminary evaluation …

Source: Canadian Research Initiative in Substance Misuse (CRISM), Canadian Institutes of Health Research (CIHR)
Format: PDF
Publié : 2019
Sujets : Réduction des méfaits, Naloxone, Substances spécifiques